Literature DB >> 20854967

Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy.

Valentina O Puntmann1, Cosima Jahnke, Rolf Gebker, Bernhard Schnackenburg, Kevin F Fox, Eckart Fleck, Ingo Paetsch.   

Abstract

Different pathophysiologic pathways in the development of left ventricular (LV) hypertrophy can be reflected in phenotypical differences. A total of 119 subjects (39 with hypertension [HTN]; 43 with nonobstructive hypertrophic cardiomyopathy [HC], and 37 control subjects) underwent a standardized cardiac magnetic resonance imaging protocol for assessment of global and regional morphology and function using balanced steady-state free precession sequences and late gadolinium enhancement studies. Compared to controls, both hypertrophic groups had significantly greater maximal wall thickness and LV mass index (p <0.01). The patients with HTN had reduced ejection fraction, increased heart cavities, and increased LV wall stress (p <0.01). The HC group had supernormal ejection fraction and reduced LV wall stress (p <0.01). The HTN group had reduced anteroseptal systolic strains (p <0.02), and the HC group displayed a marked decrease in longitudinal systolic strain (p <0.01). In the HC group, an inverse relation was seen between a globally increased late gadolinium enhancement score and the ejection fraction (r = -0.5, p = 0.01), and between regional late gadolinium enhancement scores and regional systolic strain in the inferoseptal segments. Increased LV wall stress was identified as the hallmark of HTN (odds ratio 1.2, p = 0.002), while HC was best characterized by reduced total longitudinal strain (odds ratio 1.3, p = 0.002). In conclusion, our findings indicate the presence of distinctive hypertrophic phenotypes detectable by means of multiparametric magnetic resonance imaging. In HTN, impaired deformation follows the distribution of LV wall stress. On the contrary, HC is characterized by reduced global and regional deformation, in association with fibrosis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20854967     DOI: 10.1016/j.amjcard.2010.05.036

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.

Authors:  Petri Sipola; Jarkko Magga; Minna Husso; Pertti Jääskeläinen; Keijo Peuhkurinen; Johanna Kuusisto
Journal:  Eur Radiol       Date:  2011-01-28       Impact factor: 5.315

2.  MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.

Authors:  Minako Takeda; Yasuo Amano; Masaki Tachi; Hitomi Tani; Kyoichi Mizuno; Shinichiro Kumita
Journal:  Jpn J Radiol       Date:  2013-08-31       Impact factor: 2.374

Review 3.  Clinical applications of multiparametric CMR in left ventricular hypertrophy.

Authors:  Sabrina Nordin; Luke Dancy; James C Moon; Daniel M Sado
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-03       Impact factor: 2.357

4.  Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.

Authors:  Tomas G Neilan; Francois-Pierre Mongeon; Ravi V Shah; Otavio Coelho-Filho; Siddique A Abbasi; John A Dodson; Ciaran J McMullan; Bobak Heydari; Gregory F Michaud; Roy M John; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2013-11-27

5.  Shape analysis of hypertrophic and hypertensive heart disease using MRI-based 3D surface models of left ventricular geometry.

Authors:  Siamak Ardekani; Saurabh Jain; Alianna Sanzi; Celia P Corona-Villalobos; Theodore P Abraham; M Roselle Abraham; Stefan L Zimmerman; Katherine C Wu; Raimond L Winslow; Michael I Miller; Laurent Younes
Journal:  Med Image Anal       Date:  2015-12-10       Impact factor: 8.545

6.  Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy.

Authors:  Ermelinda Pennacchini; Maria Beatrice Musumeci; Stefano Fierro; Pietro Francia; Camillo Autore
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-13       Impact factor: 3.738

7.  Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

Authors:  Richard E Katholi; Daniel M Couri
Journal:  Int J Hypertens       Date:  2011-06-30       Impact factor: 2.420

8.  Cardiovascular magnetic resonance in systemic hypertension.

Authors:  Alicia M Maceira; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-06-11       Impact factor: 5.364

9.  Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.

Authors:  Jonathan C L Rodrigues; Stephen Rohan; Amardeep Ghosh Dastidar; Iwan Harries; Christopher B Lawton; Laura E Ratcliffe; Amy E Burchell; Emma C Hart; Mark C K Hamilton; Julian F R Paton; Angus K Nightingale; Nathan E Manghat
Journal:  Eur Radiol       Date:  2016-07-01       Impact factor: 5.315

10.  Texture signatures of native myocardial T1 as novel imaging markers for identification of hypertrophic cardiomyopathy patients without scar.

Authors:  Ulf Neisius; Hossam El-Rewaidy; Selcuk Kucukseymen; Connie W Tsao; Jennifer Mancio; Shiro Nakamori; Warren J Manning; Reza Nezafat
Journal:  J Magn Reson Imaging       Date:  2020-01-23       Impact factor: 5.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.